Carmell Therapeutics Corp (Carmell) is a biotechnology company which develops and commercializes plasma-based bio-active materials (PBMs). Its product pipeline includes bone healing accelerant for treatment of long bone fractures, shoulder repair, spine fusion and total joint replacement; and tissue healing accelerant against surgical wounds, partial and full thickness grafts and primary healing in chronic wound beds. The company utilizes its PBM technology platform, which cross links lyophilized plasma into solid and semi-solid plasma-based materials, to treat wounds and reduce infections. It develops products in the therapeutic areas of orthopedics, soft tissue healing, burns and dermatology. Carmell is headquartered in Pittsburgh, Pennsylvania, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Carmell Therapeutics Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Carmell Therapeutics Corp Company Overview
- Carmell Therapeutics Corp Company Snapshot
- Carmell Therapeutics Corp Pipeline Products and Ongoing Clinical Trials Overview
- Carmell Therapeutics Corp - Pipeline Analysis Overview
- Carmell Therapeutics Corp - Key Facts
- Carmell Therapeutics Corp - Major Products and Services
- Carmell Therapeutics Corp Pipeline Products by Development Stage
- Carmell Therapeutics Corp Ongoing Clinical Trials by Trial Status
- Carmell Therapeutics Corp Pipeline Products Overview
- Bone Healing Accelerant - DBM Spine
- Bone Healing Accelerant - DBM Spine Product Overview
- Bone Healing Accelerant - Foot/Ankle Fusion
- Bone Healing Accelerant - Foot/Ankle Fusion Product Overview
- Bone Healing Accelerant - Foot/Ankle Fusion Clinical Trial
- Bone Healing Accelerant - Long Bone (Tibia) Fractures
- Bone Healing Accelerant - Long Bone (Tibia) Fractures Product Overview
- Bone Healing Accelerant - Long Bone (Tibia) Fractures Clinical Trial
- Bone Healing Accelerant - Shoulder Repair
- Bone Healing Accelerant - Shoulder Repair Product Overview
- Bone Healing Accelerant - Total Joint Replacement
- Bone Healing Accelerant - Total Joint Replacement Product Overview
- REPAIR Surgical Scaffold
- REPAIR Surgical Scaffold Product Overview
- Tissue Healing Accelerant - C-Section/Hysterectomy
- Tissue Healing Accelerant - C-Section/Hysterectomy Product Overview
- Tissue Healing Accelerant - Chronic Wound Beds
- Tissue Healing Accelerant - Chronic Wound Beds Product Overview
- Tissue Healing Accelerant - Colorectal Surgery
- Tissue Healing Accelerant - Colorectal Surgery Product Overview
- Tissue Healing Accelerant - Partial And Full Thickness Grafts
- Tissue Healing Accelerant - Partial And Full Thickness Grafts Product Overview
- Tissue Healing Accelerant - Sternotomy
- Tissue Healing Accelerant - Sternotomy Product Overview
- Tissue Healing Accelerant - Surgical Wound Healing
- Tissue Healing Accelerant - Surgical Wound Healing Product Overview
- Carmell Therapeutics Corp - Key Competitors
- Carmell Therapeutics Corp - Key Employees
- Carmell Therapeutics Corp - Locations And Subsidiaries
- Head Office
- Recent Developments
- Carmell Therapeutics Corp, Recent Developments
- Jan 07, 2020: Carmell Therapeutics receives IND clearance for CT-101, bone healing accelerant
- Mar 07, 2019: Carmell Therapeutics announces publication of results of pre-clinical studies on its tissue healing accelerant for the treatment of cutaneous radiation injury
- Feb 04, 2019: Carmell Therapeutics to present at the 21st Annual BIO CEO & Investor Conference in New York
- Jan 03, 2019: Carmell Therapeutics names Wendy F. Dicicco as board director
- Dec 20, 2018: Carmell Therapeutics president & CEO, Randy Hubbell, to present at Biotech Showcase 2019 in San Francisco
- Jun 22, 2017: Carmell Therapeutics announced the issuance of Canadian Patent No. 2701187 for METHODS AND APPARATUS FOR MANUFACTURING PLASMA BASED PLASTICS
- Jun 22, 2017: Carmell Therapeutics announced the issuance of Canadian Patent No. 2701187 for Methods and Apparatus for Manufacturing Plasma Based Plastics
- May 09, 2017: Carmell Therapeutics expands manufacturing capabilities to support Phase III clinical trials
- Oct 05, 2016: Carmell Therapeutics New Management Team
- Jun 24, 2016: Carmell announces the awarding of a new U.S. Patent that covers the use of the Company’s plasma-based materials as drug delivery vehicles
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Carmell Therapeutics Corp Pipeline Products and Ongoing Clinical Trials Overview
- Carmell Therapeutics Corp Pipeline Products by Equipment Type
- Carmell Therapeutics Corp Pipeline Products by Indication
- Carmell Therapeutics Corp Ongoing Clinical Trials by Trial Status
- Carmell Therapeutics Corp, Key Facts
- Carmell Therapeutics Corp, Major Products and Services
- Carmell Therapeutics Corp Number of Pipeline Products by Development Stage
- Carmell Therapeutics Corp Pipeline Products Summary by Development Stage
- Carmell Therapeutics Corp Ongoing Clinical Trials by Trial Status
- Carmell Therapeutics Corp Ongoing Clinical Trials Summary
- Bone Healing Accelerant - DBM Spine - Product Status
- Bone Healing Accelerant - DBM Spine - Product Description
- Bone Healing Accelerant - Foot/Ankle Fusion - Product Status
- Bone Healing Accelerant - Foot/Ankle Fusion - Product Description
- Bone Healing Accelerant - Foot/Ankle Fusion - A Study to Evaluate the Safety and Efficacy of the Bone Healing Accelerant
- Bone Healing Accelerant - Long Bone (Tibia) Fractures - Product Status
- Bone Healing Accelerant - Long Bone (Tibia) Fractures - Product Description
- Bone Healing Accelerant - Long Bone (Tibia) Fractures - A Multiregion, Randomized, Controlled, Blinded Study of the Safety and Efficacy of Bone Healing Accelerant Versus Standard of Care in Subjects with Open Tibia Fractures
- Bone Healing Accelerant - Shoulder Repair - Product Status
- Bone Healing Accelerant - Shoulder Repair - Product Description
- Bone Healing Accelerant - Total Joint Replacement - Product Status
- Bone Healing Accelerant - Total Joint Replacement - Product Description
- REPAIR Surgical Scaffold - Product Status
- REPAIR Surgical Scaffold - Product Description
- Tissue Healing Accelerant - C-Section/Hysterectomy - Product Status
- Tissue Healing Accelerant - C-Section/Hysterectomy - Product Description
- Tissue Healing Accelerant - Chronic Wound Beds - Product Status
- Tissue Healing Accelerant - Chronic Wound Beds - Product Description
- Tissue Healing Accelerant - Colorectal Surgery - Product Status
- Tissue Healing Accelerant - Colorectal Surgery - Product Description
- Tissue Healing Accelerant - Partial And Full Thickness Grafts - Product Status
- Tissue Healing Accelerant - Partial And Full Thickness Grafts - Product Description
- Tissue Healing Accelerant - Sternotomy - Product Status
- Tissue Healing Accelerant - Sternotomy - Product Description
- Tissue Healing Accelerant - Surgical Wound Healing - Product Status
- Tissue Healing Accelerant - Surgical Wound Healing - Product Description
- Carmell Therapeutics Corp, Key Employees
- Glossary
- Carmell Therapeutics Corp Pipeline Products by Equipment Type
- Carmell Therapeutics Corp Pipeline Products by Development Stage
- Carmell Therapeutics Corp Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Avalon Biomed Inc
- Brasseler USA Inc
- Cosmedent Inc
- Synergy Biomedical LLC
- Synergy Biomedical LLC
- Cosmedent Inc
- Brasseler USA Inc
- Avalon Biomed Inc
